2015
Can a Computerized Simulator Assess Skill Level and Improvement in Performance of ERCP?
Sahakian AB, Laine L, Jamidar PA, Siddiqui UD, Duffy A, Ciarleglio MM, Deng Y, Nagar A, Aslanian HR. Can a Computerized Simulator Assess Skill Level and Improvement in Performance of ERCP? Digestive Diseases And Sciences 2015, 61: 722-730. PMID: 26572779, DOI: 10.1007/s10620-015-3939-7.Peer-Reviewed Original ResearchConceptsTotal procedure timeProcedure timePrimary outcomeAcademic tertiary referral centerShorter total procedure timeTertiary referral centerPerformance of ERCPReferral centerCohort studyRetrograde cholangiographyERCP proceduresTrainee experienceGastroenterology fellowsSurgical skills centerFlexible endoscopyERCP trainingLittle dataGastroenterology facultyERCPSignificant differencesConsiderable riskSession 2Session 1Baseline sessionsOutcomes
2008
Fellow Involvement May Increase Adenoma Detection Rates During Colonoscopy
Rogart JN, Siddiqui UD, Jamidar PA, Aslanian HR. Fellow Involvement May Increase Adenoma Detection Rates During Colonoscopy. The American Journal Of Gastroenterology 2008, 103: ajg2008568. PMID: 18759826, DOI: 10.1111/j.1572-0241.2008.02085.x.Peer-Reviewed Original ResearchConceptsAdenoma detection rateRetrospective studyFellow involvementPercentage of patientsAdvanced adenomasSurveillance colonoscopyMore adenomasDetection rateProcedure timeColonoscopyFellow participationAdenomasGI fellowsSignificant differencesPatientsFurther investigationAttendingsDifferent studiesVisual scanningInvolvementTotal numberFellowsQuality indicatorsTechnical aspects
2005
Oral allopurinol does not prevent the frequency or the severity of post-ERCP pancreatitis
Mosler P, Sherman S, Marks J, Watkins JL, Geenen JE, Jamidar P, Fogel EL, Lazzell-Pannell L, Temkit M, Tarnasky P, Block KP, Frakes JT, Aziz AA, Malik P, Nickl N, Slivka A, Goff J, Lehman GA. Oral allopurinol does not prevent the frequency or the severity of post-ERCP pancreatitis. Gastrointestinal Endoscopy 2005, 62: 245-250. PMID: 16046988, DOI: 10.1016/s0016-5107(05)01572-5.Peer-Reviewed Original ResearchConceptsPost-ERCP pancreatitisOral allopurinolAllopurinol groupControl groupOxygen-derived free radical productionPlacebo 4 hoursProcedure risk factorsCommon major complicationSeverity of pancreatitisFree radical productionProphylactic allopurinolPatient demographicsMajor complicationsOverall incidencePostprocedure pancreatitisPharmacologic agentsRisk factorsPancreatitisPatientsStandardized criteriaAllopurinolERCPSeveritySignificant differencesIncidence